Top Undervalued Biotechnology industry Stocks 2026

Relay Therapeutics, (RLAY) is the most undervalued stock in the Biotechnology industry with an estimated 29.7% upside, followed by ADMA Biologics, (ADMA) at 24.6%, Absci (ABSI) at 16.2%, and Vertex Pharmaceuticals (VRTX) at 15.2%.

Updated todayBased on intrinsic value modelsIndustry: Biotechnology

Page snapshot: 13 July 2026, 10:42 pm

View full analysis in the screener → · All undervalued →

Before you trade on valuation alone

Cross-check fair value with fundamentals, liquidity, and your own goals—this table is a screen, not advice.

Check if a stock is undervalued See intrinsic value →

Biotechnology Industry Valuation Insights (Updated Today)

The Biotechnology industry currently shows an average upside of 21.4% on this snapshot.
Top name Relay Therapeutics, Inc. (RLAY) trades at roughly a 29.7% discount to modeled intrinsic value—rankings move with prices and inputs.

Undervalued Biotechnology Stocks by Market Cap

Large cap (top 5)

1.Vertex Pharmaceuticals Incorporated · VRTX15.2%$123.19B

Mid cap (top 5)

1.Relay Therapeutics, Inc. · RLAY29.7%$3.5B
2.ADMA Biologics, Inc. · ADMA24.6%$2.1B

Small cap (top 5)

1.Absci Corporation · ABSI16.2%$1.8B

What Are Undervalued Biotechnology Stocks?

Undervalued biotechnology stocks are names where price sits below modeled fair (intrinsic) value—often expressed as positive headline upside versus the current quote.

This is not a buy list. Validate each symbol on its company page before you act.

How We Identify Undervalued Biotechnology Stocks

We pull an industry-filtered undervalued snapshot (price, intrinsic value, upside, cap, sector, country) and rank by headline upside. You can sort and search in the table above.

Rankings can shift intraday as prices and model inputs move. Use the stock screener for custom filters beyond this industry leaderboard.

FAQs

Answers about undervalued biotechnology names, intrinsic value, and how often this list refreshes.

What are undervalued biotechnology stocks?

They are Biotechnology names trading below modeled intrinsic value—shown here as upside % versus price. Models vary; use this as a screen, not advice.

How do you find undervalued biotechnology stocks?

We load undervalued names for this industry from our API, then rank and filter in the table. Sort columns and open company pages to dig deeper.

Why are biotechnology stocks undervalued?

Often sentiment, earnings, cycles, rates, or stock-specific news—not always a “misprice.” Intrinsic value is model-dependent.

Are undervalued biotechnology stocks a good investment?

Not by label alone. Discounts can reflect risk or data lag. Check fundamentals and your goals; seek professional advice if needed.

How often is this list updated?

The page rebuilds on a schedule (ISR). Live quotes can move faster—use company pages for the latest.